Aim Immunotech Inc (NY: AIM )
0.3280
-0.0031
(-0.94%)
Official Closing Price
Updated: 8:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Press Releases about Aim Immunotech Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Provides Update Regarding Annual Meeting
November 28, 2023
From AIM ImmunoTech Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231105960127/en/1935756/5/Activist_Group_Web_of_Interconnections.jpg)
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
March 14, 2023
Exposures
Product Safety
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Announces Corporate Governance Enhancements
November 09, 2022
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Board Issues Letter to Shareholders
October 26, 2022
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
September 19, 2022
From AIM ImmunoTech Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From AIM ImmunoTech Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.